V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160014489 | 160007116 | 1.71 | 77.1 | Palliative (P) | 2018-12-02 | 2018-12-02 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 101555001 |
| 160014492 | 160007117 | 1.78 | 80 | Palliative (P) | 2018-01-11 | 2018-01-25 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | DOXORUBICIN + OLARATUMAB | 101346588 |
| 160014493 | 160007118 | 1.75 | 76.9 | Palliative (P) | 2016-05-10 | 2016-05-24 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100360096 |
| 160014494 | 160007119 | 1.69 | 82.5 | Curative (C) | 2016-12-05 | 2016-12-05 | EW EuroEwing 2012 Arm B VDC | 02 | N | HYDROXYCARBAMIDE | 101349691 |
| 160014497 | 160007120 | 1.69 | 20.4 | Palliative (P) | 2019-08-29 | 2019-09-12 | Doxorubicin + Ifosfamide | 02 | N | EW EUROEWING 2012 ARM B VDC | 100551067 |
| 160014499 | 160007121 | 0 | 13.2 | Palliative (P) | 2018-10-23 | 2018-10-25 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100693487 |
| 160014501 | 160007122 | 1.63 | 78.3 | Palliative (P) | 2018-02-28 | 2018-02-28 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100218332 |
| 160014505 | 160007123 | 1.66 | 70 | null | 2019-08-09 | 2019-08-16 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100939300 |
| 160014507 | 160007124 | 1.6 | 85.4 | Palliative (P) | 2017-05-21 | 2017-05-30 | Pemetrexed | 02 | Y | CEDIRANIB | 100233488 |
| 160014508 | 160007125 | 1.73 | 75 | Palliative (P) | 2019-05-04 | 2019-05-18 | VIDE | 02 | N | PACLITAXEL | 100706412 |
| 160014509 | 160007126 | 1.55 | 62.2 | Palliative (P) | 2016-12-12 | 2016-12-14 | Doxorubicin + Ifosfamide | N | N | DOXORUBICIN | 100486085 |
| 160014510 | 160007127 | 1.75 | 86 | Palliative (P) | null | 2019-05-17 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101087567 |
| 160014511 | 160007128 | 1.69 | 103.2 | Curative (C) | 2016-06-12 | 2016-06-21 | IDELALISIB | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101662955 |
| 160014512 | 160007129 | 1.86 | 76.1 | Curative (C) | 2012-12-05 | 2012-12-25 | Carboplatin AUC 6 - 10 | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101437422 |
| 160014513 | 160007130 | 1.52 | 72.8 | Neo-adjuvant (N) | 2016-12-23 | 2016-12-26 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | NOT MATCHED | 100533218 |
| 160014515 | 160007131 | 1.65 | null | Neo-adjuvant (N) | 2018-09-16 | 2018-10-04 | NB Low/Interm risk guidelines Carbo/Etop | N | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101855520 |
| 160014516 | 160007132 | 1.71 | 65 | Neo-adjuvant (N) | 2018-09-13 | 2018-09-17 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100405224 |
| 160014517 | 160007133 | 1.67 | 69.3 | Palliative (P) | 2017-04-12 | 2017-04-22 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100697104 |
| 160014523 | 160007134 | 1.74 | 78.9 | Curative (C) | 2017-11-03 | 2017-11-12 | Liposomal Doxorubicin (Caelyx) | N | N | DOXORUBICIN + IFOSFAMIDE | 100449668 |
| 160014524 | 160007135 | 1.57 | 74 | null | 2017-11-13 | 2017-11-13 | CISPLATIN + ETOPOSIDE | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101249030 |
| 160014526 | 160007136 | 1.58 | 50 | Palliative (P) | 2019-11-24 | 2019-12-11 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101800230 |
| 160014528 | 160007137 | 1.64 | 79.8 | Palliative (P) | 2018-11-15 | 2018-12-03 | ICON8B TRIAL | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100235130 |
| 160014529 | 160007138 | 1.75 | 89.2 | null | 2018-10-12 | 2018-10-12 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | null | ETOP 13-18 BEAT-MESO TRIAL | 101546082 |
| 160014531 | 160007139 | 1.74 | 58 | Neo-adjuvant (N) | 2016-08-13 | 2016-08-13 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100695372 |
| 160014535 | 160007140 | 1.84 | 44 | Curative (C) | 2018-06-17 | 2018-06-21 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101030235 |
| 160014536 | 160007141 | 1.63 | 104 | Palliative (P) | 2016-10-06 | 2016-10-20 | Pemetrexed | 02 | null | CARBOPLATIN + GEMCITABINE | 101782471 |
| 160014537 | 160007142 | 1.77 | 95 | Curative (C) | 2016-06-30 | 2016-07-08 | ICON8B TRIAL | 2 | N | LIPOSOMAL DOXORUBICIN | 100887348 |
| 160014538 | 160007143 | 1.59 | 120 | Curative (C) | 2019-02-14 | 2019-03-05 | CYCLOPHOSPHAMIDE | 02 | null | VINCRISTINE | 101301703 |
| 160014542 | 160007145 | 1.82 | 83 | Palliative (P) | null | 2019-05-22 | DOXORUBICIN | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101145722 |
| 160014543 | 160007146 | 1.72 | 91.75 | Curative (C) | 2017-09-17 | 2017-09-29 | VAC | 01 | N | ETOP 13-18 BEAT-MESO TRIAL | 100056894 |
| 160014544 | 160007147 | 1.8 | 60.2 | Curative (C) | 2018-01-27 | 2018-02-04 | CYCLOPHOSPHAMIDE + EPIRUBICIN | Y | N | CTD | 100691811 |
| 160014545 | 160007148 | 1.08 | 79.9 | Palliative (P) | 2016-11-14 | 2016-11-29 | null | 02 | N | PACLITAXEL | 100089872 |
| 160014546 | 160007149 | 0 | 76.6 | 03 | 2019-04-22 | 2019-04-22 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101743154 |
| 160014547 | 160007150 | 1.68 | 60.8 | Palliative (P) | 2017-05-29 | 2017-06-06 | Doxorubicin + Ifosfamide | 02 | N | PACLITAXEL | 101697477 |
| 160014550 | 160007151 | 0 | 18.2 | Neo-adjuvant (N) | 2017-06-08 | 2017-07-04 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | ECX | 101792658 |
| 160014551 | 160007152 | 1.77 | 79 | Palliative (P) | null | 2020-02-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101039771 |
| 160014553 | 160007153 | 1.72 | 66.3 | null | 2017-12-12 | 2017-12-12 | Trial Unspecified | 02 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100283369 |
| 160014554 | 160007154 | 1.66 | 95.45 | null | 2017-04-04 | 2017-04-08 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101764101 |
| 160014556 | 160007156 | 1.54 | 69.5 | Palliative (P) | 2016-05-02 | 2016-05-15 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100849224 |
| 160014557 | 160007157 | 1.81 | 59.8 | Palliative (P) | 2020-04-24 | 2020-05-02 | Liposomal Doxorubicin 40mg/m2 | N | null | DOXORUBICIN | 101290598 |
| 160014558 | 160007158 | 1.89 | 119 | Palliative (P) | 2018-03-25 | 2018-03-29 | Bevacizumab+Carbo+Pacliaxel | 02 | N | TRIAL UNSPECIFIED | 100878708 |
| 160014559 | 160007159 | 1.64 | 86.5 | Neo-adjuvant (N) | 2018-09-19 | 2018-09-21 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100184229 |
| 160014561 | 160007161 | 1.81 | 0 | Adjuvant (A) | 2017-04-26 | 2017-04-28 | Bevacizumab 7.5mg/kg | 02 | N | TRIAL UNSPECIFIED | 101381083 |
| 160014562 | 160007162 | 1.76 | 71.6 | Palliative (P) | 2017-04-01 | 2017-04-02 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100661388 |
| 160014563 | 160007163 | 1.84 | 61 | Palliative (P) | null | 2018-06-16 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101494304 |
| 160014564 | 160007164 | 1.74 | 72 | Palliative (P) | 2017-07-28 | 2017-08-07 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101218089 |
| 160014566 | 160007165 | 1.63 | 86.8 | Palliative (P) | null | 2018-12-23 | Trial Unspecified | 02 | null | ETOP 13-18 BEAT-MESO TRIAL | 100288604 |
| 160014571 | 160007166 | null | 47 | Curative (C) | 2019-03-20 | 2019-03-20 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100911570 |
| 160014573 | 160007167 | 1.64 | 113 | Neo-adjuvant (N) | 2017-09-11 | 2017-09-11 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | IBRUTINIB | 101169864 |
| 160014576 | 160007168 | 1.77 | 67 | Curative (C) | 2017-09-13 | 2017-09-16 | Imatinib 400mg | Y | N | DOXORUBICIN + IFOSFAMIDE | 100880224 |